EMRISE CORPORATION Appoints Boenning & Scattergood, Inc. as Financial Advisor

Business Wire, June 24, 2009

Boenning to Assist with Strategic Business Plans Designed to Enhance Shareholder Value

EATONTOWN, N.J. -- EMRISE CORPORATION (NYSE Arca: ERI), a multi-national manufacturer of defense and aerospace electronic devices and communications equipment, today announced that it has engaged Boenning & Scattergood, Inc. (“Boenning”) as its exclusive financial advisor to support the Company’s growth strategy by assisting EMRISE in identifying and negotiating potential strategic merger, acquisition or alliance targets, by assisting EMRISE in securing a new line of credit, and by providing general financial advisory and support services as EMRISE executes its ongoing strategic business plans designed to enhance shareholder value.

EMRISE Chairman, President and Chief Executive Officer, Carmine T. Oliva, said that Boenning was selected from a number of leading investment banking firms who had expressed interest in working with EMRISE. Oliva added, “We believe that Boenning is the right financial advisor for EMRISE, in part, due to the quality and experience of the investment banking team who will be working with us and also because of the breadth of services they offer. We are also impressed with the firm’s recent growth in this otherwise dismal investment banking market and their track record of successfully completing financings, acquisition and sale transactions for companies in the defense, aerospace and communications sectors.” In addition to M&A advisory services, Boenning provides public and private capital raising services, equity research, institutional and retail sales.

About Boenning & Scattergood, Inc.

Founded in 1914, Boenning & Scattergood, Inc. is a full-service firm providing M&A advisory, public and private capital raising services, equity research, institutional and retail sales, and equity trading to high quality firms across the globe. The firm is one of the nation’s fastest growing investment banks, with key hires across all areas of the firm of highly experienced individuals from prior firms including JP Morgan, Hambrecht & Quist, Cowen, Morgan Stanley and Bank of America. The defense, electronics and communications industries are a central focus for the firm, from both an equity research and investment banking standpoint. Boenning has significant investment banking resources, which includes a team of managing directors with collective experience of more than 250 transactions that exceed $75 billion in capital raised. For more information, please visit www.boenninginc.com.

About EMRISE Corporation

EMRISE designs, manufactures and markets electronic devices, sub-systems and equipment for aerospace, defense, industrial and communications markets. EMRISE products perform key functions such as power supply and power conversion; RF and microwave signal processing; network access and timing and synchronization of communications networks. Primary growth driver applications for EMRISE products include RF devices for RCIED jamming systems and Edge Network Timing and Synchronization equipment. EMRISE serves customers in North America, Europe and Asia through operations in the United States, England and France. The Company has built a worldwide base of customers including a majority of the Fortune 100 in the U.S. that do business in markets served by EMRISE and many similar-size companies in Europe and Asia. For more information go to www.emrise.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

With the exception of historical information, the matters discussed in this press release, including without limitation, EMRISE’s expectation that Boenning will assist in identifying and negotiating potential strategic merger, acquisition or alliance targets, the expectation that Boenning will assist EMRISE in securing a new line of credit, and EMRISE’s ability to execute ongoing strategic business plans designed to enhance shareholder value, are all forward-looking statements that involve a number of risks and uncertainties. The actual future results of EMRISE could differ from those statements. Factors that could cause or contribute to such differences include, but are not limited to, failure to successfully identify or negotiate a potential strategic merger, acquisition or alliance target, failure to successfully secure a new line of credit, failure to execute ongoing strategic business plans or failure of such plans to enhance shareholder value, lower than expected sales and/or profitability, economic factors, political factors; and those factors contained in the “Risk Factors” Section of EMRISE’s most recently filed Form 10-K, and other EMRISE filings with the Securities and Exchange Commission.